• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
KONG Ruifang ,LIN Ang.Pertussis and current status of pertussis vaccine development[J].Journal Of Pharmaceutical Research,2025,44(12):1200-1207[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2335times   Download 713次 QR Code for this article
Scan with your phone!
百日咳及其疫苗研发进展
孔瑞芳1,2,林昂1,2
Font:Larger+|Default|Smaller-
(1.中国药科大学基础医学与临床药学学院,江苏 南京 211198;2.中国药科大学新药安全评价研究中心,江苏 南京 211198)
摘要:
百日咳是一种由百日咳鲍特菌引起的急性呼吸道传染病,近年来百日咳疫情复现,暴露出疫苗接种、诊疗策略不佳等诸多公共卫生问题。本文从流行病学、病原学、应对策略、疫苗推演等方面进行综述。介绍已获批上市的百日咳疫苗(全细胞百日咳疫苗、无细胞百日咳疫苗)和新型在研百日咳疫苗(基因减毒疫苗、外膜囊泡疫苗、mRNA疫苗等)的优缺点,并对比孕妇接种和家庭茧式免疫两种新式接种方法及应对策略。总结疫苗迭代对百日咳鲍特菌突变、疫情复现和群体免疫的影响,并提出改进方案。
关键词:  百日咳鲍特菌  百日咳疫苗  免疫应答  群体免疫
DOI:10.13506/j.cnki.jpr.2025.12.009
基金项目:国家重点研发计划“病原学与防疫技术体系研究”项目(No.2025YFC2311904);国家自然科学基金面上项目(No.32471004)
Publication Date:December 25, 2025
Pertussis and current status of pertussis vaccine development
KONG Ruifang 1,2,LIN Ang1,2
(1. School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China; 2. Center for Safety Evaluation of New Drugs, China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Pertussis, an acute respiratory infectious disease caused by Bordetella pertussis, has re-emerged in recent years, exposing critical public health challenges in vaccination and treatment strategies. This review comprehensively summarizes the epidemiology, pathogenesis, intervention strategies, and vaccine development. We evaluate the advantages and limitations of licensed vaccines (whole-cell and acellular pertussis vaccines) and analyze novel vaccine candidates under development (genetically attenuated vaccines, outer membrane vesicle vaccines, mRNA vaccines, etc.). Furthermore, we compare two different immunization strategies, maternal vaccination and the cocooning strategy, and analyze the impact of vaccine pressure on bacterial mutation dynamics, disease resurgence, and herd immunity. Finally, we propose recommendations for improved control of pertussis.
Key words:  Bordetella pertussis  Pertussis vaccines  Immune response  Herd immunity
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.